Newronika
Company · Milan, Italy
Italian company developing adaptive (closed-loop) deep brain stimulation that adjusts to brain signals in real time.
In the news
Clinical trialsImplants
First patient implanted in Newronika's pivotal trial of adaptive deep brain stimulation
The ADVENT study will compare adaptive and conventional DBS in 104 people with Parkinson's disease across the US and Europe.
RegulationNeuromodulation
Newronika's adaptive deep brain stimulator wins CE mark in Europe
AlphaDBS continuously senses brain signals and adjusts stimulation automatically for Parkinson's disease.